메뉴 건너뛰기




Volumn 16, Issue 11, 1998, Pages 1467-1473

Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in node mouse xenografts

Author keywords

Farnesyltransferase; Geranylgeranyltransferase; Prenylation and antitumor efficacy; Ras

Indexed keywords

FARNESYL TRANS TRANSFERASE; GERANYLGERANYLTRANSFERASE 1; GERANYLGERANYLTRANSFERASE INHIBITOR; GERANYLTRANSFERASE; GGTI 297; MITOGEN ACTIVATED PROTEIN KINASE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE; ONCOPROTEIN; PRENYLAMINE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; TRANSFERASE; UNCLASSIFIED DRUG;

EID: 0032546264     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201656     Document Type: Article
Times cited : (221)

References (45)
  • 4
    • 0024376173 scopus 로고
    • Bos JL. (1989). Cancer Res., 49, 4682-4689.
    • (1989) Cancer Res. , vol.49 , pp. 4682-4689
    • Bos, J.L.1
  • 25


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.